Cassava Sciences Inc vs Fastly Inc — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Fastly Inc trades at $28.5 (market cap $4.42B). The key difference: Fastly Inc is far larger — about 92.6× Cassava Sciences Inc's market cap, and Fastly Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | FSLY | |
|---|---|---|
Market Cap | $47.75M | $4.42B |
Sector | Health | Technology |
52-Week High | $4.64 | $33.50 |
52-Week Low | $0.87 | $6.85 |
Enterprise Value | -$34.93M | $4.48B |
Trailing returns across standard periods
Latest headlines on both assets
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →Fastly operates a content delivery network, which is necessary for entities to provide faster and more reliable online content. Fastly's strategy differs from traditional CDNs, which focused on locating servers in as many locations as possible to store copies of files that consumers most use. Fastly has far fewer sites than traditional CDNs, but it houses servers in the most network-dense data centers. Instead of simply storing static content, it allows its customers to program on its platform, enabling edge computing and better service of the more dynamic content that was traditionally not well served by CDNs. Fastly gears its service to the largest, most sophisticated enterprises rather than small companies and generated about two thirds of its revenue in the United States in 2020.
Read more on FSLY →